BORIS, Brother of the Regulator of Imprinted Sites, Is Aberrantly Expressed in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BORIS, Brother of the Regulator of Imprinted Sites, Is Aberrantly Expressed in Hepatocellular Carcinoma

Published:2013-02 Issue:2 Volume:17 Page:160-165
ISSN:1945-0265
Container-title:Genetic Testing and Molecular Biomarkers
language:en
Short-container-title:Genetic Testing and Molecular Biomarkers

Author:

Chen Kefei¹,Huang Wenqing²,Huang Bin³,Wei YongGang¹,Li Bo¹,Ge Yan³,Qin Yang²

Affiliation:

1. Division of Liver Transplantation, Department of Surgery, West China Hospital, Chengdu, China.

2. Institute of Biochemistry and Molecular Biology, West China University of Medical Sciences, Chengdu, China.

3. Regenerative Medicine Center, West China Hospital, Chengdu, China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics (clinical),General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/gtmb.2012.0242

Reference28 articles.

1. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma

2. BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours

3. Hepatocellular carcinoma pathogenesis: from genes to environment

4. The epigenetic progenitor origin of human cancer

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic acid vaccines‐based therapy for triple‐negative breast cancer: A new paradigm in tumor immunotherapy arena;Cell Biochemistry and Function;2024-03-29

2. The function of brother of the regulator of imprinted sites in cancer development;Cancer Gene Therapy;2022-11-14

3. Establishment and evaluation of cell and animal models expressing BORIS subfamily 2 variant;Annals of Translational Medicine;2022-06

4. CTCFL expression is associated with cerebral vascular abnormalities;Tissue and Cell;2021-10

5. Recent developments in targeting genes and pathways by RNAi‐based approaches in colorectal cancer;Medicinal Research Reviews;2020-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3